Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion type Assertion NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_head.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion description "[Collectively, such findings suggest that IL-23 and/or IL-17A inhibitors should be evaluated for their therapeutic and preventative potential in human cancers, especially in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_provenance.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion evidence source_evidence_literature NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_provenance.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion SIO_000772 26457610 NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_provenance.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion wasDerivedFrom befree-2016 NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_provenance.
- NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_assertion wasGeneratedBy ECO_0000203 NP1294839.RALL1FD8IoT-XZLeJ8iTV0aGFJyJsYEOcSarBbwQXFMVQ130_provenance.